Vertex Pharmaceuticals Incorporated Financial Ratios — VRTX34

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	4.58	-11.99	-37.78	-60.75	-55.22	-10.69	16.54	64.88	22.37	36.71	24.93	27.67	22.99	-3.15	22.54
Return on Assets (%)	1.51	-4.31	-17.53	-31.74	-23.02	-4.15	8.18	42.83	16.16	27.02	18.6	21.04	17.71	-2.37	16.41
Return on Capital (%)	3.6	- -	- -	- -	- -	- -	- -	- -	20.84	33.76	23.15	26	22.02	-3.29	20.41
Return on Invested Capital (%)	6.36	- -	- -	- -	- -	- -	- -	- -	17	30.04	22.73	25.79	18.95	2.73	18.17
Gross Margin (%)	94.29	81.67	89.25	89.49	87.94	87.64	88.95	86.56	86.84	88.14	88.06	87.9	87.21	86.11	86.24
EBITDA Margin (%)	10.55	5.56	-46.34	-108.4	-39.19	4.19	7.42	23.22	31.33	47.79	38.39	49.89	40.66	-0.23	36.52
Operating Margin (%)	15.72	3.18	-12.92	-110.52	-45.01	0.66	15.78	21.79	28.87	46.24	36.69	47.59	38.31	-2.12	37.95
Incremental Operating Margin (%)	72.3	- -	65.12	76.78	39.12	71.04	48.52	48.51	48.25	81.62	- -	108.45	- -	- -	487.95
Pretax Margin (%)	4.28	2.1	-51.65	-126.61	-54.03	-3.96	-0.63	19.7	33.51	50.23	36.05	47.39	44.38	2.25	38.69
Profit Margin (%)	2.1	-7.01	-36.72	-127.25	-53.89	-6.58	10.59	68.8	28.27	43.7	30.92	37.2	36.68	-4.86	32.94
Net Income to Common Margin (%)	2.1	-7.01	-36.72	-127.25	-53.89	-6.58	10.59	68.8	28.27	43.7	30.92	37.2	36.68	-4.86	32.94
Effective Tax Rate (%)	31.87	- -	- -	- -	- -	- -	- -	- -	15.64	13	14.22	21.51	17.36	315.53	14.86
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	4.58	-11.99	-37.78	-60.75	-55.22	-10.69	16.54	64.88	22.37	36.71	24.93	27.67	22.99	-3.15	22.54

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	456	697	507	825	826	841	606	587	662	932	967	900	808	1,744	2,031
ST Debt	- -	14	17	32	87	319	23	5	39	42	80	89	84	87	77
LT Debt	456	683	490	793	739	521	584	582	623	890	887	810	725	1,657	1,953
Total Debt/EBITDA	3.06	8.21	-0.9	-1.31	-2.04	11.79	3.28	0.83	0.51	0.31	0.33	0.2	0.2	-67.87	0.46
Net Debt/EBITDA	-0.51	-1.05	1.01	0.53	1.04	-12.39	-9.02	-3.75	-2.38	-2.02	-2.34	-2.36	-2.58	177.81	-1.16
Total Debt/EBIT	4.01	14.91	-0.83	-1.19	-1.77	84.62	4.92	0.92	0.55	0.33	0.35	0.21	0.21	-7.49	0.49
Net Debt/EBIT	-0.66	-1.91	0.93	0.48	0.9	-88.96	-13.51	-4.17	-2.6	-2.1	-2.44	-2.44	-2.71	19.62	-1.22
EBITDA to Interest Expense	3.95	5.65	-24.5	-8.63	-4.8	0.88	2.66	9.76	22.3	50.96	47.28	81.31	91	-0.84	329.56
EBITDA-CapEx/Interest Expense	1.44	0.92	-26.74	-9.34	-5.34	0.18	-1.08	8.45	21.01	46.49	43.46	77.57	85.15	-16.7	296.65
EBIT to Interest Expense	5.88	3.23	-6.83	-8.8	-5.52	0.14	5.67	9.16	20.55	49.3	45.19	77.55	85.72	-7.63	342.44
Interest Expense	38	15	23	73	84	81	69	72	59	58	62	55	44	31	13
Common Equity/Total Assets	35.7	36.21	58.49	46.05	37.62	39.93	57.21	71.01	73.15	73.92	75.19	76.65	77.34	72.82	72.79
Long-Term Debt/Equity (%)	49.11	57.13	36.1	72.34	67.61	38.96	28.59	13.11	10.24	10.24	8.78	5.82	4.12	10.1	10.46
Long-Term Debt/Capital (%)	32.93	36.1	26.29	41.27	38.51	23.93	22.04	11.58	9.23	9.25	8.02	5.47	3.94	9.13	9.44
Long-Term Debt/Total Assets (%)	20.68	24.76	21.12	33.96	29.59	18	16.47	9.31	7.49	7.57	6.6	4.46	3.19	7.35	7.62
Total Debt/Equity (%)	49.11	58.28	37.35	75.26	75.55	62.83	29.69	13.23	10.87	10.73	9.58	6.47	4.6	10.63	10.88
Total Debt/Capital (%)	32.93	36.82	27.19	42.94	43.04	38.59	22.9	11.68	9.81	9.69	8.74	6.07	4.4	9.61	9.81
Total Debt/Total Assets (%)	20.68	25.26	21.84	35.33	33.07	29.02	17.1	9.4	7.95	7.93	7.2	4.96	3.56	7.74	7.92
Net Debt to Equity	-8.11	-7.48	-41.97	-30.15	-38.37	-66.06	-81.55	-59.75	-51.1	-68.93	-67.28	-75.5	-58.98	-27.85	-27.24
Net Debt/Capital (%)	-8.29	-6.37	-44.01	-25.5	-34.82	-88.84	-169.37	-111.73	-85.48	-164.94	-159.04	-243.8	-129.3	-33.64	-32.57
EBITDA	149	85	-562	-629	-405	71	185	708	1,304	2,966	2,908	4,456	4,013	-26	4,383
EBITDA-CapEx	54	14	-613	-680	-450	15	-75	612	1,229	2,706	2,673	4,251	3,755	-511	3,946
Operating Income (Loss)	222	49	-157	-641	-465	11	393	664	1,202	2,869	2,779	4,250	3,780	-233	4,554

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.47	3.05	3.68	3.77	2.06	1.81	2.59	2.83	2.85	3.55	3.51	3.93	3.16	1.72	1.71
Current Ratio	3.39	3.67	3.99	4.2	2.78	2.31	3.28	3.43	3.61	4.33	4.46	4.83	3.99	2.69	2.9
Quick Ratio	2.94	3.39	3.92	4.01	2.43	2.11	3.07	3.19	3.33	4.02	4.04	4.46	3.6	2.17	2.24
CFO/Avg Current Liab	0.33	0.65	-0.15	-1.5	-0.84	0.36	1.06	1.32	1.28	2.03	1.32	1.69	1.12	-0.14	0.98
Common Equity/Total Assets	35.7	36.21	58.49	46.05	37.62	39.93	57.21	71.01	73.15	73.92	75.19	76.65	77.34	72.82	72.79
Long-Term Debt/Equity (%)	49.11	57.13	36.1	72.34	67.61	38.96	28.59	13.11	10.24	10.24	8.78	5.82	4.12	10.1	10.46
Long-Term Debt/Capital (%)	32.93	36.1	26.29	41.27	38.51	23.93	22.04	11.58	9.23	9.25	8.02	5.47	3.94	9.13	9.44
Long-Term Debt/Total Assets (%)	20.68	24.76	21.12	33.96	29.59	18	16.47	9.31	7.49	7.57	6.6	4.46	3.19	7.35	7.62
Total Debt/Equity (%)	49.11	58.28	37.35	75.26	75.55	62.83	29.69	13.23	10.87	10.73	9.58	6.47	4.6	10.63	10.88
Total Debt/Capital (%)	32.93	36.82	27.19	42.94	43.04	38.59	22.9	11.68	9.81	9.69	8.74	6.07	4.4	9.61	9.81
Total Debt/Total Assets (%)	20.68	25.26	21.84	35.33	33.07	29.02	17.1	9.4	7.95	7.93	7.2	4.96	3.56	7.74	7.92
CFO/Total Liabilities	11.27	17.13	-6.3	-46.27	-26.01	15.15	56.19	70.15	70.27	106.15	79.32	97.44	68.69	-8.04	52.05
CFO/CapEx	1.52	3.76	-1.18	-11.19	-8.07	4.17	3.26	13.31	20.81	12.52	11.25	20.18	13.69	-1.01	8.3
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	17.13	14.71	13.08	13.66	15.14	11.97	12.66

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	14.42	9.36	10.6	7.19	8.27	9.1	10.33	8.82	7.98	8.17	7.49	6.93	6.57	6.95	6.55
Days Sales Outstanding	25.31	39.01	34.45	50.77	44.16	40.12	35.32	41.38	45.73	44.67	48.72	52.7	55.58	52.54	55.69
Inventory Turnover	1.43	3.92	5.84	2.71	2.83	3.12	2.9	3.47	3.75	3.28	2.85	2.66	2.1	1.57	1.14
Days Inventory Outstanding	254.87	93.17	62.49	134.64	129.06	116.9	125.66	105.25	97.23	111.12	127.94	137.46	173.42	231.83	319.64
Accounts Payable Turnover	3.49	2.25	1.51	1.29	2.06	3.39	4.57	4.56	5.95	7	5.58	4.76	4.61	5.13	4.88
Accounts Payable Turnover Days	104.52	162.23	241.21	283.12	176.77	107.82	79.91	79.98	61.33	52.14	65.43	76.65	79.24	71.09	74.85
Cash Conversion Cycle	175.67	-30.05	-144.27	-97.7	-3.55	49.2	81.08	66.65	81.64	103.65	111.24	113.51	149.76	213.29	300.48
Inventory to Cash Days	-229.56	-54.17	-28.05	-83.87	-84.9	-76.78	-90.34	-63.87	-51.5	-66.45	-79.22	-84.76	-117.84	-179.29	-263.95
Inventories	112	30	14	31	57	78	112	124	168	281	353	461	739	1,205	1,687
Raw Materials	32	4	- -	9	9	6	21	10	26	46	42	38	79	252	260
Work In Process	47	11	10	21	41	57	74	88	107	161	224	261	525	769	1,197
Finished Goods	33	15	4	2	8	15	17	27	34	73	87	162	135	185	230
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	58,544	63,115	58,748	77,321	109,603	106,835	120,750
- Cash & Cash Equivalents	475	489	569	625	715	1,184	1,665	2,650	3,109	5,988	6,795	10,504	10,369	4,570	5,085
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	142	197	- -	21	154	182	14	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	456	697	507	825	826	841	606	587	662	932	967	900	808	1,744	2,031
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	55,397	57,388	52,191	67,442	99,193	102,463	116,172
Total Capital	1,384	1,893	1,863	1,921	1,920	2,179	2,649	5,022	6,747	9,619	11,067	14,812	18,389	18,154	20,696
Total Debt/Capital (%)	32.93	36.82	27.19	42.94	43.04	38.59	22.9	11.68	9.81	9.69	8.74	6.07	4.4	9.61	9.81
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.01	0.02	0.02	0.01	0.01	0.02	0.02
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	13.31	9.25	6.89	7.55	10.05	9.3	9.68
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	42.47	19.35	17.95	15.14	24.72	- -	26.5
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	46.26	20.09	18.76	15.66	25.89	- -	27.84
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	34.22	17.37	19.36	16.16	27.76	- -	31.89
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	35.9	18.85	21.2	17	29.92	- -	36.25
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	58,924	63,966	59,999	77,949	110,796	107,234	122,655
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	55,777	58,239	53,442	68,071	100,386	102,862	118,078
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	6.43	6.64	6.16	7.88	11.57	11.98	13.74
TTM Sales	1,411	1,527	1,212	580	1,032	1,702	2,489	3,048	4,163	6,206	7,574	8,931	9,869	11,020	12,001
TTM EBITDA	149	85	-562	-629	-405	71	185	708	1,304	2,966	2,908	4,456	4,013	-26	4,383
TTM Operating Income	222	49	-157	-641	-465	11	393	664	1,202	2,869	2,779	4,250	3,780	-233	4,554
TTM Cash Flow to Firm	169	- -	- -	- -	- -	- -	- -	- -	1,619	3,304	2,696	4,173	3,574	-559	3,643
TTM Free Cash Flow to Firm	75	- -	- -	- -	- -	- -	- -	- -	1,543	3,044	2,461	3,968	3,315	-1,044	3,205

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	39.44	21.37	24.91	19.86	33.79	-109.65	38.4
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	46.26	20.09	18.76	15.66	25.89	- -	27.84
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	55,397	57,388	52,191	67,442	99,193	102,463	116,172
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	5.33	6.35	5.54	6.8	8.82	12.2	11.57
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	13.31	9.25	6.89	7.55	10.05	9.3	9.68
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	42.47	19.35	17.95	15.14	24.72	- -	26.5
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	49.31	23.27	25.4	23.19	30.28	- -	30.75
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	44.99	24.24	23.37	21.96	25.04	- -	29.93
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	50.36	30.13	28.25	25.89	30.91	- -	34.65
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	38.67	20.25	20.29	17.46	20.91	- -	24.9
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	9.62	7.27	5.82	5.56	6.23	6.51	6.47
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	8.78	7.57	5.35	5.26	5.15	7.36	6.3
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	9.82	9.41	6.47	6.2	6.36	8.5	7.29
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	7.54	6.32	4.65	4.18	4.3	6.36	5.24
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	12.5	8.66	6.75	6.33	7	7.37	7.04
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	11.41	9.03	6.21	5.99	5.79	8.33	6.85
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	12.77	11.22	7.51	7.06	7.15	9.62	7.93
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	9.8	7.54	5.4	4.76	4.83	7.2	5.7
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	13.94	10.17	7.85	8.63	11.11	9.73	10.13
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	12.72	10.59	7.22	8.17	9.18	11	9.86
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	14.24	13.16	8.74	9.63	11.34	12.7	11.42
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	10.93	8.85	6.27	6.49	7.67	9.5	8.2
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	36.98	19.4	22.5	18.66	30.99	-217.69	33.48
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	33.74	20.2	20.7	17.67	25.62	-245.99	32.58
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	37.76	25.11	25.03	20.83	31.63	-284.1	37.73
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	29	16.88	17.98	14.04	21.39	-212.59	27.11
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	35.98	22.26	22.92	18.8	27.94	-123.9	37.38
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	40.28	27.66	27.71	22.17	34.49	-143.09	43.28
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	30.93	18.59	19.9	14.95	23.33	-107.08	31.1
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	12.07	9.67	6.27	7.09	8.13	10.56	9.41
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	13.61	12.24	7.76	8.56	10.28	12.26	10.96
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	10.27	7.93	5.33	5.41	6.61	9.07	7.77
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	38.53	20.24	16.33	14.22	19.99	- -	25.77
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	43.42	25.62	20.22	17.15	25.28	- -	30
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	32.78	16.59	13.88	10.84	16.26	- -	21.27
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	41.97	21.01	17.07	14.7	20.93	- -	27.07
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	47.3	26.6	21.13	17.75	26.48	- -	31.51
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	35.71	17.22	14.51	11.22	17.03	- -	22.34
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	6.79	7.3	6.94	9.04	12.78	12.49	14.29
High Price	- -	- -	- -	- -	- -	- -	- -	- -	6.94	9.45	7.71	10.09	13.05	16.31	16.1
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	50,265	60,022	47,483	63,339	80,211	116,352	112,954
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	56,637	75,982	58,780	76,436	101,476	135,053	131,503
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	42,759	49,198	40,369	48,314	65,265	99,963	93,215

Shares Outstanding	6,966	7,231	7,780	8,046	8,197	8,263	8,428	8,492	8,619	8,649	8,469	8,553	8,576	8,551	8,453
Diluted Weighted Avg Shares	6,949	7,054	7,485	7,831	8,031	8,143	8,427	8,626	8,675	8,766	8,649	8,623	8,669	8,583	8,586
Basic Weighted Avg Shares	6,819	7,054	7,485	7,831	8,031	8,143	8,282	8,463	8,544	8,647	8,576	8,523	8,576	8,583	8,510
Revenue per Share	0.21	0.22	0.16	0.07	0.13	0.21	0.3	0.36	0.49	0.72	0.88	1.05	1.15	1.28	1.41
EBITDA per Share	0.02	0.01	-0.08	-0.08	-0.05	0.01	0.02	0.08	0.15	0.34	0.34	0.52	0.47	- -	0.52
Operating Income per Share	0.03	0.01	-0.02	-0.08	-0.06	- -	0.05	0.08	0.14	0.33	0.32	0.5	0.44	-0.03	0.54
Basic EPS, GAAP	- -	-0.02	-0.06	-0.09	-0.07	-0.01	0.03	0.25	0.14	0.31	0.27	0.39	0.42	-0.06	0.46
Basic EPS from Cont Ops	0.01	- -	-0.07	-0.09	-0.07	-0.01	0.01	0.25	0.14	0.31	0.27	0.39	0.42	-0.06	0.46
Diluted EPS, GAAP	- -	-0.02	-0.06	-0.09	-0.07	-0.01	0.03	0.24	0.14	0.31	0.27	0.39	0.42	-0.06	0.46
Diluted EPS from Cont Ops	0.01	- -	-0.07	-0.09	-0.07	-0.01	0.01	0.24	0.14	0.31	0.27	0.39	0.42	-0.06	0.46
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.02	0.04	-0.01	-0.07	-0.05	0.03	0.1	0.15	0.18	0.38	0.31	0.48	0.41	-0.06	0.43
Free Cash Flow per Basic Share	0.01	0.03	-0.01	-0.08	-0.05	0.02	0.07	0.14	0.17	0.35	0.28	0.46	0.38	-0.11	0.38
Cash & Equivalents per Share	0.14	0.18	0.19	0.17	0.13	0.17	0.25	0.37	0.44	0.77	0.89	1.26	1.31	0.72	0.78
Book Value per Share	0.11	0.14	0.17	0.13	0.11	0.14	0.24	0.52	0.71	1	1.19	1.63	2.05	1.92	2.21
Tangible Book Value per Share	0.01	0.04	0.17	0.13	0.07	0.1	0.23	0.52	0.54	0.84	1.03	1.43	1.83	1.7	2.03

Vertex Pharmaceuticals Incorporated

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)